The Recall Desk
SevereFDA (Drugs)·D-0388-2026·Announced 2026-03-11

Silintan herbal pills recalled as Class I for undeclared meloxicam

123Herbals is recalling Silintan 25-count pill bottles because FDA analysis revealed the presence of undeclared meloxicam. The FDA has classified this recall as Class I.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The rubric states an FDA Class I recall is never scored below 4, and this record carries a Class I classification with no reported deaths in the source.

Plain-English summary

Anthony Trinh of 123Herbals LLC is recalling SILINTAN, 25 pills packaged in a 25-count bottle, made by Shanghai Chinese Medical Works of Shanghai, China. The product was distributed nationwide in the United States.

The product was marketed without an approved New Drug Application or Abbreviated New Drug Application, and FDA analysis revealed the presence of undeclared meloxicam. The FDA has classified this recall as Class I, its most serious category.

All lots within expiry are affected.

Consumers can identify affected product by the product name and packaging above, and may contact 123Herbals LLC for further information.

The recalled product

Product
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Manufacturer
ANTHONY TRINH, 123Herbals LLC
Category
Drug — Herbal supplement
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed nationwide across the United States.

Related recalls

Same hazard · undeclared ingredient

See all →